T. Rowe Price Associates
ELAN icon

T. Rowe Price Associates’s Elanco Animal Health ELAN Stock Holding History

T. Rowe Price Associates’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.6M Buy
3,201,490
+404,737
+14% +$9.89M 0.01% 669
2025
Q4 		$63.3M Buy
2,796,753
+2,378,455
+569% +$51.8M 0.01% 739
2025
Q3 		$8.43M Buy
418,298
+23,100
+6% +$387K ﹤0.01% 1269
2025
Q2 		$5.64M Sell
395,198
-6,717
-2% -$78.5K ﹤0.01% 1241
2025
Q1 		$4.22M Sell
401,915
-154,557
-28% -$1.75M ﹤0.01% 1299
2024
Q4 		$6.74M Sell
556,472
-2,479,034
-82% -$32.4M ﹤0.01% 1212
2024
Q3 		$44.6M Sell
3,035,506
-25,032,216
-89% -$349M 0.01% 785
2024
Q2 		$405M Buy
28,067,722
+5,928,704
+27% +$94.7M 0.05% 306
2024
Q1 		$360M Buy
22,139,018
+852,281
+4% +$13.3M 0.04% 323
2023
Q4 		$317M Buy
21,286,737
+1,365,731
+7% +$15.5M 0.04% 330
2023
Q3 		$224M Buy
19,921,006
+2,494,084
+14% +$29M 0.03% 370
2023
Q2 		$175M Buy
17,426,922
+105,179
+0.6% +$976K 0.02% 414
2023
Q1 		$163M Sell
17,321,743
-1,329,896
-7% -$15.7M 0.02% 415
2022
Q4 		$228M Sell
18,651,639
-8,379,249
-31% -$104M 0.04% 352
2022
Q3 		$335M Buy
27,030,888
+4,872,640
+22% +$85.2M 0.06% 278
2022
Q2 		$435M Sell
22,158,248
-12,354,858
-36% -$292M 0.06% 321
2022
Q1 		$900M Buy
34,513,106
+48,052
+0.1% +$1.28M 0.09% 224
2021
Q4 		$978M Sell
34,465,054
-12,502,789
-27% -$389M 0.09% 229
2021
Q3 		$1.5B Buy
46,967,843
+188,117
+0.4% +$6.31M 0.14% 147
2021
Q2 		$1.62B Buy
46,779,726
+5,006,187
+12% +$165M 0.15% 146
2021
Q1 		$1.23B Buy
41,773,539
+332,959
+0.8% +$10.2M 0.12% 186
2020
Q4 		$1.27B Buy
41,440,580
+442,967
+1% +$13.5M 0.13% 169
2020
Q3 		$1.15B Sell
40,997,613
-4,882,365
-11% -$124M 0.13% 164
2020
Q2 		$984M Sell
45,879,978
-784,642
-2% -$17.3M 0.12% 173
2020
Q1 		$1.04B Buy
46,664,620
+13,279,963
+40% +$364M 0.17% 133
2019
Q4 		$983M Sell
33,384,657
-3,831,422
-10% -$104M 0.13% 175
2019
Q3 		$990M Sell
37,216,079
-5,116,462
-12% -$153M 0.14% 161
2019
Q2 		$1.43B Buy
42,332,541
+3,653,638
+9% +$119M 0.2% 121
2019
Q1 		$1.24B Buy
38,678,903
+35,844,944
+1,265% +$1.1B 0.18% 127
2018
Q4 		$89.4M Buy
2,833,959
+16,433
+0.6% +$538K 0.02% 636
2018
Q3 		$98.3M Buy
+2,817,526
New +$99.1M 0.01% 675

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

T. Rowe Price Associates's ELAN Position: Q1 2026 in Review

T. Rowe Price Associates increased its Elanco Animal Health (ELAN) stake by 14% in Q1 2026, buying an estimated $9.89M and bringing the position to 3,201,490 shares worth $76.6M. The position accounts for 0.01% of the portfolio, ranked #669.

T. Rowe Price Associates first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $1.62B in Q2 2021. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • T. Rowe Price Associates held 3,201,490 shares of Elanco Animal Health worth $76.6M as of Q1 2026.
  • T. Rowe Price Associates bought 404,737 Elanco Animal Health shares in Q1 2026, an estimated $9.89M.
  • Elanco Animal Health made up 0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #669 holding.
  • T. Rowe Price Associates first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
  • T. Rowe Price Associates's Elanco Animal Health position peaked at $1.62B in Q2 2021.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.